|Articles|July 1, 2018
- Pharmaceutical Executive-07-01-2018
- Volume 38
- Issue 7
Pharmaceutical Executive, July 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive July 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Opioid Litigation: Evading the Widening Crosshairsover 7 years ago
Patient & Customer-Centric Commercializationover 7 years ago
Compliance: The Critical Cog in Pharma Machineover 7 years ago
Gaining Ground with Stem Cells: Gil Van Bokkelen, Athersysalmost 8 years ago
A Seat at the Strategy Tablealmost 8 years ago
Regulatory Innovation Generates Breakthroughsalmost 8 years ago
China’s Biopharma Rise: Opportunities and ThreatsNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Q&A: Supply Chain Fallout From Iran War, Tariff Uncertainty
2
Pharmaceutical Executive Daily: Shah Capital's Plan to Vote Against Novavax Board Nominees
3
Medical Supply Chains at Risk Over Escalating Conflicts in Iran: Report
4
Novavax Stock Increases as Shah Capital Plans to Vote Against Board Nominees
5